JP2022545287A5 - - Google Patents
Info
- Publication number
- JP2022545287A5 JP2022545287A5 JP2022512449A JP2022512449A JP2022545287A5 JP 2022545287 A5 JP2022545287 A5 JP 2022545287A5 JP 2022512449 A JP2022512449 A JP 2022512449A JP 2022512449 A JP2022512449 A JP 2022512449A JP 2022545287 A5 JP2022545287 A5 JP 2022545287A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- subject
- radiation
- induced
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024212337A JP2025032222A (ja) | 2019-08-24 | 2024-12-05 | Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法 |
| JP2026089220A JP2026127687A (ja) | 2019-08-24 | 2026-05-27 | Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891338P | 2019-08-24 | 2019-08-24 | |
| US62/891,338 | 2019-08-24 | ||
| PCT/US2020/047692 WO2021041347A1 (en) | 2019-08-24 | 2020-08-24 | Methods of treatment using bcn057 and bcn512 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024212337A Division JP2025032222A (ja) | 2019-08-24 | 2024-12-05 | Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545287A JP2022545287A (ja) | 2022-10-26 |
| JP2022545287A5 true JP2022545287A5 (enExample) | 2023-10-25 |
Family
ID=74647168
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512449A Pending JP2022545287A (ja) | 2019-08-24 | 2020-08-24 | Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法 |
| JP2024212337A Pending JP2025032222A (ja) | 2019-08-24 | 2024-12-05 | Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法 |
| JP2026089220A Pending JP2026127687A (ja) | 2019-08-24 | 2026-05-27 | Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024212337A Pending JP2025032222A (ja) | 2019-08-24 | 2024-12-05 | Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法 |
| JP2026089220A Pending JP2026127687A (ja) | 2019-08-24 | 2026-05-27 | Ｂｃｎ０５７及びｂｃｎ５１２を用いる治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11358964B2 (enExample) |
| EP (1) | EP4017493A4 (enExample) |
| JP (3) | JP2022545287A (enExample) |
| CN (1) | CN114728001A (enExample) |
| AU (2) | AU2020337892B2 (enExample) |
| WO (1) | WO2021041347A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118541368A (zh) * | 2021-09-03 | 2024-08-23 | 比西恩生物科学有限责任公司 | 使用bcn057、bcn077及类似物的治疗方法 |
| US20240122916A1 (en) * | 2022-10-08 | 2024-04-18 | Radmit, Inc. | Effect of YEL002 on Conditions and Diseases |
| US20240325375A1 (en) * | 2023-04-01 | 2024-10-03 | Radmit, Inc. | Effect of YEL002 on Psychological and Psychiatric Factors in Health and Disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4159331A (en) * | 1978-05-05 | 1979-06-26 | The Upjohn Company | Antihypertensive 4-aminoquinolines |
| US8227603B2 (en) * | 2006-08-01 | 2012-07-24 | Cytokinetics, Inc. | Modulating skeletal muscle |
| WO2008016648A2 (en) * | 2006-08-01 | 2008-02-07 | Cytokinetics, Incorporated | Certain chemical entities, compositions and methods |
| US20180104233A1 (en) * | 2016-10-16 | 2018-04-19 | BCN Biosciences L.L.C. | Methods of treatment and pharmaceutical compositions using bcn057 or bcn512 |
| AU2018316185A1 (en) * | 2017-08-08 | 2020-03-26 | BCN Biosciences L.L.C. | Methods of treating radiation induced gastrointestinal syndrome (RIGS) and related disease states using compound 512 |
| AU2018346962A1 (en) * | 2017-10-12 | 2020-05-28 | BCN Biosciences L.L.C. | Methods of treating radiation induced gastrointestinal syndrome |
-
2020
- 2020-08-24 AU AU2020337892A patent/AU2020337892B2/en active Active
- 2020-08-24 EP EP20857259.4A patent/EP4017493A4/en active Pending
- 2020-08-24 US US17/001,592 patent/US11358964B2/en active Active
- 2020-08-24 WO PCT/US2020/047692 patent/WO2021041347A1/en not_active Ceased
- 2020-08-24 CN CN202080074897.6A patent/CN114728001A/zh active Pending
- 2020-08-24 JP JP2022512449A patent/JP2022545287A/ja active Pending
-
2022
- 2022-06-13 US US17/839,199 patent/US12435081B2/en active Active
-
2024
- 2024-12-05 JP JP2024212337A patent/JP2025032222A/ja active Pending
-
2025
- 2025-11-15 AU AU2025267506A patent/AU2025267506A1/en active Pending
-
2026
- 2026-05-27 JP JP2026089220A patent/JP2026127687A/ja active Pending